Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Epilepsy and SLC22A1[original query] |
|---|
| Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. British journal of clinical pharmacology 2016 Apr . Milosheska Daniela, Lorber Bogdan, Vovk Tomaž, Kastelic Matej, Dolžan Vita, Grabnar Izt |
| A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy. Therapeutic drug monitoring 2018 9 40 (6): 730-737. Chen Yanan, Xu Shansen, Wang Zhanyou, Zhao Mingming, Wang Huanxin, Lu Tong, Zhao Lim |
| Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy. Frontiers in pharmacology 2019 8 10 832. Wang Zhan-Zhang, Zhang Yue-Feng, Huang Wen-Can, Wang Xi-Pei, Ni Xiao-Jiao, Lu Hao-Yang, Hu Jin-Qing, Deng Shu-Hua, Zhu Xiu-Qing, Xie Huan-Shan, Chen Hong-Zhen, Zhang Ming, Qiu Chang, Wen Yu-Guan, Shang De-W |
| Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy. The pharmacogenomics journal 2020 Jun . Ortega-Vázquez Alberto, Fricke-Galindo Ingrid, Dorado Pedro, Jung-Cook Helgi, Martínez-Juárez Iris E, Monroy-Jaramillo Nancy, Rojas-Tomé Irma S, Peñas-Lledó Eva, Llerena Adrián, López-López Maris |
- Page last reviewed:Feb 1, 2024
- Content source: